EGFR and lung carcinoma: Not surprisingly, multiple components in the EGFR-Akt-mTOR pathway were highly expressed/activated in the A549 lung cancer cells but not in HSAEC-2KT normal lung cells (Figure 7C, 7D and Supplementary Figure 7), which is consistent with their oncogenetic functions.